Controversies in NEN : An ENETS position statement on the endoscopic management of localised gastric, duodenal and rectal neuroendocrine neoplasms
Open Access
- 16 June 2025
- journal article
- review article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 37 (12) , e70060
Abstract
Gastric, duodenal and rectal neuroendocrine tumours (NETs) are increasingly detected due to advances in endoscopic imaging. While international guidelines provide criteria for endoscopic management, several aspects remain controversial due to limited high‐quality evidence. This position paper, developed by an expert panel, aims to clarify these unresolved issues and provide consensus‐based recommendations. The primary objective of this position paper is to critically analyse and address key controversies in the endoscopic management of gastro‐duodenal‐rectal NETs. These include the optimal selection of endoscopic resection techniques, the significance of R1 resections, pathological assessment and surveillance strategies. Special attention is given to site‐specific challenges, including the role of Ki‐67 in type 1 gastric NETs, the management of multiple gastric lesions, the feasibility of endoscopic resection for type 3 gastric NETs and the limitations of advanced endoscopic techniques in the duodenum. This position paper was developed using an Expert Panel Consensus methodology. Topics were identified during the 2024 ENETS Advisory Board meeting and addressed through a structured literature review. Evidence was critically appraised, and expert discussions were conducted to identify key points. By reviewing controversial aspects of endoscopic management, this position paper will provide practical guidance to optimise decision‐making and improve outcomes for patients with gastro‐duodenal‐rectal NETs. Multidisciplinary evaluation remains crucial to tailoring treatment strategies based on tumour characteristics, patient factors and procedural risks.Keywords
This publication has 63 references indexed in Scilit:
- Gastroenteropancreatic Neuroendocrine Tumor Incidence by Sex and Age in the USJAMA Oncology, 2025
- A new endoscopic tumor grading for rectal neuroendocrine tumors: Correlation of vascular pattern with histopathologyDigestive and Liver Disease, 2024
- Optimization of endoscopic treatment strategies for R0 resection of rectal neuroendocrine tumors smaller than 10 mmClinics and Research in Hepatology and Gastroenterology, 2024
- Clinical significance of positive resection margin for patients with rectal neuroendocrine tumors within 20 mm following initial endoscopic resection: A multi-center studyEuropean Journal of Surgical Oncology, 2024
- Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED)Digestive and Liver Disease, 2024
- Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre studyDigestive and Liver Disease, 2022
- Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective studyDigestive and Liver Disease, 2019
- A uniform residual tumor (R) classificationCancer, 2009
- Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatmentBest Practice & Research Clinical Gastroenterology, 2005
- Duodenal and ampullary carcinoid tumorsVirchows Archiv, 1986